Your browser doesn't support javascript.
loading
Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
Sage, William; Guilfoyle, Mathew; Luney, Catriona; Young, Adam; Sinha, Rohitashwa; Sgubin, Donatella; McAbee, Joseph H; Ma, Ruichong; Jefferies, Sarah; Jena, Rajesh; Harris, Fiona; Allinson, Kieren; Matys, Tomasz; Qian, Wendi; Santarius, Thomas; Price, Stephen; Watts, Colin.
Afiliação
  • Sage W; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Guilfoyle M; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Luney C; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Young A; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Sinha R; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Sgubin D; Division of Neurosurgery, Azienda Ospedaliera Nazionale SS, Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • McAbee JH; Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.
  • Ma R; Department of Neurosurgery, John Radcliffe Hospital NHS Foundation Trust, Oxford, UK.
  • Jefferies S; Department of Oncology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Jena R; Department of Oncology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Harris F; Department of Oncology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Allinson K; Department of Histopathology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Matys T; Department of Radiology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Qian W; Cambridge Cancer Trial Centre, Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Santarius T; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Price S; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Watts C; Division of Neurosurgery, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK. cw209@cam.ac.uk.
J Neurooncol ; 136(2): 273-280, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29139095
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carmustina / Glioblastoma / Antineoplásicos Alquilantes / Ácido Aminolevulínico Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carmustina / Glioblastoma / Antineoplásicos Alquilantes / Ácido Aminolevulínico Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Ano de publicação: 2018 Tipo de documento: Article